Healthcare News and Research

Latest Healthcare News and Research

Life Care Medical Devices inks exclusive distribution agreement with M.E.D. Surgical

Life Care Medical Devices Ltd., a development stage medical device company today announced that Life Care Medical Devices, Ltd, Ireland signed an exclusive agreement with M.E.D. Surgical, a subsidiary of Sisk Healthcare for the distribution of the Company's Keyhole Cup Laparoscopic Access Device in the Republic of Ireland territories and Northern Ireland.

8 Jul 2013

Soligenix announces personalized medicine collaboration with SciClone

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced a personalized medicine collaboration with SciClone Pharmaceuticals in the Company's oral mucositis clinical program with SGX942.

8 Jul 2013

Capricor to become wholly-owned subsidiary of Nile Therapeutics

Capricor, Inc., a privately held biotechnology company developing cardiac stem cell therapeutics to repair damaged heart muscle, and Nile Therapeutics, Inc. announced today that they have entered into a Merger Agreement under which Capricor will become a wholly-owned subsidiary of Nile Therapeutics, Inc. in an all-stock transaction.

8 Jul 2013

First Edition: July 8, 2013

Today's early morning highlights from the major news organizations, including news about a new ad campaign against the health law, more reaction to the administration's delay of the employer mandate provision and states efforts to restrict abortions.

8 Jul 2013

HeadSense closes financing for non-invasive intracranial pressure monitor

HeadSense, an early stage company developing a non-invasive neurological monitor focused initially on an intracranial pressure application, today announced it closed financing led by Pontifax, a leading Israeli VC; GE Ventures of Menlo Park, California, USA; Everett Partners, an investment group based out of Akron, Ohio, USA; and JuMaJo, an investment group from Hamburg, Germany.

8 Jul 2013

Bayer starts enrollment in BAY94-9027 Phase II/III trial for hemophilia A in children

Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A in children.

8 Jul 2013

BCSI, ORIGIO partner to advance pH monitoring solutions for IVF

Blood Cell Storage, Inc., a leading medical device provider based in Seattle, WA and ORIGIO a/s, a leader in delivering innovative Assisted Reproductive Technology solutions headquartered in Malov Denmark, announced a partnership today during the annual meeting of the European Society of Human Reproduction and Embryology.

8 Jul 2013

Study: African Americans with CLL have shorter survival times than Caucasians

A new analysis has found that among patients with chronic lymphocytic leukemia, African Americans more commonly present with advanced disease, and they tend to have shorter survival times than Caucasians despite receiving the same care.

8 Jul 2013

Dr. Steven Goldberg wins Patients' Choice Award for fifth year

Only a small percentage of the nation's physicians are ever honored with a Patients' Choice Award. But Naples Orthopedic Surgeon Dr. Steven Goldberg belongs to an even more selective group of doctors who are being honored this year as five-time Patients' Choice honorees, marking the award's fifth anniversary.

6 Jul 2013

Alzheimer's Association upset with CMS draft decision on brain amyloid imaging

The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services draft coverage decision on brain amyloid imaging, particularly given the clear, scientific consensus recommendations provided to CMS by the Association and the Society for Nuclear Medicine and Molecular Imaging regarding appropriate, limited coverage, only in specific populations.

6 Jul 2013

Research develop new methods, technologies for reducing deliberate drinking water contamination

An international project has developed a response programme for rapidly restoring the use of drinking water networks following a deliberate contamination event.

6 Jul 2013

St. Michael Hospital receives $4.7M grant to conduct policy-driven prescription drug research

An Ontario-wide research network based at St. Michael's Hospital has received a three-year, $4.7 million grant from the province of Ontario to conduct policy-driven prescription drug research.

6 Jul 2013

Data shows individualized regimens can help optimize prophylaxis treatment in hemophilia patients

Baxter International Inc. today announced data featuring ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method], a leading recombinant treatment available worldwide, during the 24th Annual Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Amsterdam, The Netherlands.

From Baxter International Inc. 5 Jul 2013

Consanguineous marriages and older mothers increase risk of birth anomalies in children

Marriage between first cousins can more than double the risk of giving birth to a baby with a congenital anomaly (eg, heart and lung defects, Down syndrome), although the absolute risk is low, according to a multiethnic study of more than 11300 babies from the city of Bradford in the UK, published in The Lancet.

5 Jul 2013

Weekend reading: Taking stock of your body; A designer seeks to improve health care; A researcher's quest to lower suicide rates

Today, I've been on the phone four times, for an average of 24 minutes a call. My last phone call was 22 minutes 23 seconds long, according to the digital time device on my landline. It took me exactly 45 minutes and 10 seconds on the train to reach Brooklyn the other night: I counted the seconds off on my smart phone. My average mile when I ran 5K yesterday was 8 minutes and 45 seconds that showed up on the pedometer. (Nothing to boast about, I know.) ... I am able to hold my plank at the gym for 54 seconds rather than the minute I always thought I could, which I know thanks to my phone's stopwatch. My optimal sleep time is seven hours and 20 minutes and I wake up twice a night: I discovered that from a wristband that measures sleep duration and intensity.

4 Jul 2013

State highlights: Docs prescribe narcotics too often, CDC chief says; Fla. hospices get close scrutiny; Calif. Medi-Cal provider rate bump delayed

The nation's top public health official on Tuesday sharply criticized the widespread treatment of aches and pains with narcotics, saying that doctors are prescribing such drugs too soon, too often and for too long -- putting patients at risk of addiction and overdose. Dr. Tom Frieden, director of the U.S. Centers for Disease Control and Prevention, said that doctors are relying on these powerful drugs to treat chronic pain when physical therapy, exercise and other remedies would be safer and in many cases more effective (Girion and Glover, 7/2).

4 Jul 2013

Biogen, Sobi present new data supporting clinical, safety profile of ELOCTATE for hemophilia A

Biogen Idec nd Swedish Orphan Biovitrum AB (publ) presented new data that support the clinical and safety profile of their long-lasting recombinant factor VIII candidate ELOCTATE for hemophilia A.

4 Jul 2013

EyeTechCare's EyeOP1 device to be installed in four healthcare facilities in France

EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, today announces that its EyeOP1 device is to be installed in a number of hospitals in France, namely Lille University Hospital, Grenoble University Hospital and the Quinze-Vingts and Saint-Joseph hospitals in Paris. The first use of this device for the routine treatment of glaucoma patients is slated from July onwards.

4 Jul 2013

Updated EULAR recommendations for management of rheumatoid arthritis

The European League Against Rheumatism has released updated recommendations for the management of RA. According to this latest guidance, treatment with disease-modifying anti-rheumatic drugs should be initiated as soon as a diagnosis of RA is made, with the aim of reaching a target of remission or low disease activity in every patient.

4 Jul 2013

ERYTECH reports fast take-off of GRASPA Phase IIb trial in patients with acute myeloid leukemia

ERYTECH, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces a fast take-off of its Phase IIb study in Acute Myeloid Leukemia.

4 Jul 2013

Healthcare News and Research

Latest Healthcare News and Research

Life Care Medical Devices inks exclusive distribution agreement with M.E.D. Surgical

Soligenix announces personalized medicine collaboration with SciClone

Capricor to become wholly-owned subsidiary of Nile Therapeutics

First Edition: July 8, 2013

HeadSense closes financing for non-invasive intracranial pressure monitor

Bayer starts enrollment in BAY94-9027 Phase II/III trial for hemophilia A in children

BCSI, ORIGIO partner to advance pH monitoring solutions for IVF

Study: African Americans with CLL have shorter survival times than Caucasians

Dr. Steven Goldberg wins Patients' Choice Award for fifth year

Alzheimer's Association upset with CMS draft decision on brain amyloid imaging

Research develop new methods, technologies for reducing deliberate drinking water contamination

St. Michael Hospital receives $4.7M grant to conduct policy-driven prescription drug research

Data shows individualized regimens can help optimize prophylaxis treatment in hemophilia patients

Consanguineous marriages and older mothers increase risk of birth anomalies in children

Weekend reading: Taking stock of your body; A designer seeks to improve health care; A researcher's quest to lower suicide rates

State highlights: Docs prescribe narcotics too often, CDC chief says; Fla. hospices get close scrutiny; Calif. Medi-Cal provider rate bump delayed

Biogen, Sobi present new data supporting clinical, safety profile of ELOCTATE for hemophilia A

EyeTechCare's EyeOP1 device to be installed in four healthcare facilities in France

Updated EULAR recommendations for management of rheumatoid arthritis

ERYTECH reports fast take-off of GRASPA Phase IIb trial in patients with acute myeloid leukemia

Event guide: 3rd Measuring Patient Engagement Summit eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Healthcare News and Research

Latest Healthcare News and Research

Event guide: 3rd Measuring Patient Engagement Summit eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Newsletters you may be interested in